Embecta Corp. Logo

Embecta Corp.

Global producer of diabetes injection devices, like pen needles and syringes, for 30M+ people.

EMBC | NDAQ

Overview

Corporate Details

ISIN(s):
US29082K1051
LEI:
Country:
United States of America
Address:
1209 ORANGE STREET, 19801 WILMINGTON
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Embecta Corp. is a global medical device company focused on improving the lives of people with diabetes. Spun off from Becton, Dickinson and Company (BD) in 2022, the company leverages a 100-year legacy of innovation in insulin delivery. As a leading producer of diabetes injection devices, its product portfolio includes pen needles and insulin syringes that serve over 30 million people in more than 100 countries. Embecta is dedicated to developing and providing solutions for diabetes management, supported by educational resources on proper injection techniques.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Embecta Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Embecta Corp.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Embecta Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
PULSE BIOSCIENCES, INC. Logo
Developing nsPFA bioelectric tech for precise, non-thermal tissue ablation in cardiology.
United States of America PLSE
Qiagen N.V. Logo
Provides 'Sample to Insight' solutions for molecular analysis in research and clinical healthcare.
Netherlands QIA
QIAGEN N.V. Logo
Develops sample-to-insight tech for molecular diagnostics, research, and pharma applications.
United States of America QGEN
QLife Holding AB Logo
Develops an at-home IVD platform for biomarker and virus testing from blood samples.
Sweden QLIFE
IVD specialist in rapid antimicrobial susceptibility testing for critical infections like sepsis.
South Korea 317690
Quanterix Corp Logo
Offers an ultra-sensitive immunoassay platform for biomarker analysis in research and diagnostics.
United States of America QTRX
Raphas Co., Ltd. Logo
Develops dissolving microneedle patches for cosmetic, medical, and pharmaceutical applications.
South Korea 214260
Redsense Medical AB Logo
Develops FDA/CE-marked blood loss alarms for hemodialysis using fiber optic tech for EU/US markets.
Sweden REDS
RenovoRx, Inc. Logo
Develops a device platform for delivering targeted therapies directly to solid tumors.
United States of America RNXT
RESMED INC Logo
Develops cloud-connected medical devices and software for sleep apnea and respiratory care.
United States of America RMD

Talk to a Data Expert

Have a question? We'll get back to you promptly.